Publication | Closed Access

Normalization of Fecal Calprotectin Within 12 Months of Diagnosis Is Associated With Reduced Risk of Disease Progression in Patients With Crohn’s Disease

Reduced RiskFecal CalprotectinUrologyDisease ProgressionGastroenterologyPathologyClinical GastroenterologyGastrointestinal PathologyUlcerative ColitisMedicine